Regulation of CYP3A4 expression in human hepatocytes by pharmaceuticals and natural products

Drug Metabolism and Disposition

Volumn 31, Issue 5, 2003, Pages 533-539

  Raucy, Judy L ^a,b  

^a California Toxicol Res Institute   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 3A4; GINSENG EXTRACT; HERBACEOUS AGENT; KAVA; LUCIFERASE; NATURAL PRODUCT; OMEPRAZOLE; PREGNANE X RECEPTOR; SILYMARIN;

CELL STRAIN HEPG2; CONFERENCE PAPER; DOSE RESPONSE; DRUG ACCUMULATION; DRUG EFFECT; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER MICROSOME; MESSENGER RNA SYNTHESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPORTER GENE; RNA ANALYSIS; XENOBIOTIC METABOLISM;

ADOLESCENT; ADULT; AGED; BLOTTING, NORTHERN; CHILD; CHILD, PRESCHOOL; CYTOCHROME P-450 ENZYME SYSTEM; ENZYME INDUCTION; FEMALE; FLAVONOIDS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEPATOCYTES; HUMANS; MALE; MIDDLE AGED; PHARMACEUTICAL PREPARATIONS; PHARMACOLOGY; PLANT EXTRACTS; PLANT PREPARATIONS; RNA, MESSENGER;

PANAX GINSENG; PIPER METHYSTICUM;

EID: 0037403686     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: 10.1124/dmd.31.5.533     Document Type: Conference Paper

References (30)

1. Allen SW, Mueller L, Williams SN, Quattrochi LC, and Raucy JL (2001) The use of a high volume screening procedure to assess the effects of dietary flavonoids on human CYP1A1 expression. Drug Metab Dispos 29:1074-1079.
2. Carpenter SP, Lasker JM, and Raucy JL (1996) Expression, induction and catalytic activity of the ethanol-inducible cytochrome P450 (CYP2E1) in human fetal liver and hepatocytes. Mol Pharmacol 49:260-268.
3. Feierman DE and Lasker JM (1996) Metabolism of fentanyl, a synthetic opioid analgesic, by human liver microsomes. Role of CYP3A4. Drug Metab Dispos 24:932-939.
4. Foster BC, Foster MS, Vandenhoek S, Krantis A, Budzinski JW, Amason JT, Gallicano KD, and Choudri S (2001) An in vitro evaluation of human cytochrome P450 3A4 and P-glycoprotein inhibition by garlic. J Pharm Pharm Sci 4:176-184.
5. Gibson GG, Plant NJ, Swales KE, Ayrton A, and El Sankary W (2002) Receptor-dependent transcriptional activation of cytochrome P4503A genes: induction mechanisms, species differences and interindividual variation in man. Xenobiotica 32:165-206.
6. Goodwin B, Hodgson E, and Liddle C (1999) The orphan human pregnane X receptor mediates the transcriptional activation of CYP3A4 by rifampicin through a distal enhancer module. Mol Pharmacol 56:1329-1339.
7. Guengerich FP (1999) Cytochrome P4503A4: regulation and role in drug metabolism. Annu Rev Pharmacol Toxicol 39:1-17.
8. Hennessy M, Kelleher D, Spiers JP, Barry M, Kavanagh P, Back D, Mulcahy F, and Feely J (2002) St John's Wort increases expression of P-glycoprotein: implications for drug interactions. Br J Clin Pharmacol 53:75-82.
9. Jones SA, Moore LB, Shenk JL, Wisely GB, Hamilton GA, McKee DD, Tomkinson NCO, LeCluyse EL, Lambert MH, Willson TM, Kliewer SA, and Moore JT (2000) The pregnane X receptor: a promiscuous xenobiotic receptor that has diverged during evolution. Mol Endocrinol 14:27-39.
10. Lasker JM, Wester MR, Aramsombatdee E, and Raucy JL (1998) Characterization of CYP2C19 and CYP2C9 from human liver: Respective roles in microsomal tolbutamide, S-mephenytoin and omeprazole hydroxylations. Arch Biochem Biophys 353:16-28.
11. Lehmann JM, McKee DD, Watson MA, Willson TM, Moore JT, and Kliewer SA (1998) The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J Clin Investig 102:1016-1023.
12. Li AP, Rasmussen A, Xu L, and Kaminski DL (1995) Rifampicin induction of lidocaine metabolism in cultured human hepatocytes. J Pharmacol Exp Ther 274:673-677.
13. Luo G, Cunningham M, Kim S, Burn T, Lin J, Sinz M, Hamilton G, Rizzo C, Jolley S, Gilbert D et al. (2002) CYP3A4 induction by drugs: correlation between a pregnane X receptor reporter gene assay and CYP3A4 expression in human hepatocytes. Drug Metab Dispos 30:795-804.
14. Miller LG (1998) Herbal medicinals. Arch Intern Med 158:2200-2211.
15. Moore LB, Goodwin B, Jones SA, Wisely GB, Serabjit-Singh CJ, Willson TM, Collins JL, and Kliewer SA (2000a) St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor. Proc Natl Acad Sci USA 97:7500-7502.
16. Moore LB, Parks DJ, Jones SA, Bledsoe RK, Consler TG, Stimmel JB, Goodwin B, Liddle C, Blanchard SG, Willson TM, et al. (2000b) Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands. J Biol Chem 275:15122-15127.
17. Pascussi JM, Drocourt L, Fabre JM, Maurel P, and Vilarem MJ (2000) Dexamethasone induces pregnane X receptor and retinoid X receptor-α expression in human hepatocytes: synergistic increase of CYP3A4 induction by pregnane X receptor activators. Mol Pharmacol 58:361-372.
18. Piscitelli SC, Burstein AH, Chaitt D, Alfaro RM, and Falloon J (2000) Indinavir concentrations and St. John's Wort. Lancet 355:547-548.
19. Piscitelli SC, Burstein AH, Welden N, Gallicano KD, and Falloon J (2002) The effect of garlic supplements on the pharmacokinetics of saquinavir. Clin Infect Dis 34:234-238.
20. Quattrochi LC and Guzelian PS (2001) CYP3A regulation: from pharmacology to nuclear receptors. Drug Metab Dispos 29:615-622.
21. Raucy JL, Mueller L, Duan K, Allen SW, Strom S, and Lasker JM (2002a) Expression and induction of CYP2C P450 enzymes in primary cultures of human hepatocytes. J Pharmacol Exp Ther 302:475-482.
22. Raucy JL, Schultz ED, Wester MR, Arora S, Johnston DE, Omdahl JL, and Carpenter SP (1997) Human lymphocyte cytochrome P450 2E1, a putative marker for alcohol-mediated changes in hepatic chlorzoxazone activity. Drug Metab Dispos 25:1429-1435.
23. Raucy JL, Warfe LYM-F, Yueh MF, and Allen SW (2002b) A cell-based reporter gene assay for determining induction of CYP3A4 in a high volume system. J Pharmacol Exp Ther 303:412-423.
24. Runge D, Kohler C, Kostrubsky VE, Jager D, Lehmann T, Runge DM, May U, Stolz DB, Strom SC, Fleig WE, and Michalopoulos GK (2000) Induction of cytochrome P450 (CYP)1A1, CYP1A2 and CYP3A4 but not of CYP2C9, CYP2C19, multidrug resistance (MDR-1) and multidrug resistance associated protein (MRP-1) by prototypical inducers in human hepatocytes. Biochem Biophys Res Commun 273:333-341.
25. Savas U, Griffin KJ, and Johnson EF (1999) Molecular mechanisms of cytochrome P450 induction by xenobiotics: an expanded role for nuclear hormone receptors. Mol Pharmacol 56:851-857.
26. Schuetz EG, Schuetz JD, Strom SC, Thompson MT, Fisher RA, Molowa DT, Li D, and Guzelian PS (1993) Regulation of human liver cytochromes P-450 in family 3A in primary and continuous culture of human hepatocytes. Hepatology 18:1254-1262.
27. Shih H, Pickwell GV, and Quattrochi LC (2000) Differential effects of flavonoid compounds on tumor promoter-induced activation of the human CYP1A2 enhancer. Arch Biochem Biophys 373:287-294.
28. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, and Klenk DC (1985) Measurement of protein using bicinchoninic acid. Anal Biochem 150:76-85.
29. Williams SN, Shih H, Guenette DK, Brackney W, Denison MS, Pickwell GV, and Quattrochi LC (2000) Comparative studies on the effects of green tea extracts and individual tea catechins on human CYP1A gene expression. Chem Biol Interact 128:211-229.
30. Wrighton SA, Schuetz EG, Thummel KE, Shen DD, Korzekwa KR, and Watkins PB (2000) The human CYP3A subfamily: Practical considerations. Drug Metab Rev 32:339-361.